iBio, Inc. - Common Stock (IBIO)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Total 13F shares
44,512,797
Share change
+14,131,321
Total reported value
$68,540,610
Put/Call ratio
156%
Price per share
$1.54
Number of holders
91
Value change
+$21,890,326
Number of buys
55
Number of sells
25

Institutional Holders of iBio, Inc. - Common Stock (IBIO) as of Q1 2021

As of 31 Mar 2021, iBio, Inc. - Common Stock (IBIO) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,512,797 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, PRINCIPAL FINANCIAL GROUP INC, Nuveen Asset Management, LLC, JPMORGAN CHASE & CO, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC. This page lists 91 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.